PaTHway TRIAL
Research payments
$287,324
Through program year 2025, $287,324 in research payments was reported against PaTHway TRIAL, across 35 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $287,324 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Warren Greenville, NC Named on 8 payments
- Dolores Shoback San Francisco, CA Named on 6 payments
- Lisa Abbott Reno, NV Named on 5 payments
- Robert Wermers Rochester, MN Named on 4 payments
- Valerie Espinosa Austin, TX Named on 3 payments
- Howard Kenney Spokane, WA Named on 3 payments
- Mishaela Rubin New York, NY Named on 3 payments
- Rajesh Jain Burr Ridge, IL Named on 2 payments
- Chris Bajaj Ft Worth, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.